Clinical Trials Directory

Trials / Completed

CompletedNCT02628964

Electronic Cigarettes (E-cigarettes) as a Harm Reduction Strategy

Assessing the Use of Electronic Cigarettes (E-cigarettes) as a Harm Reduction Strategy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
NYU Langone Health · Academic / Other
Sex
All
Age
21 Years – 35 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to examine the feasibility of using e-cigarettes as a method for harm reduction and the effects of providing e-cigarettes (or placebo e-cigarettes) on smoking outcomes. Participants will be randomized to receive either e-cigarettes with nicotine cartridges or e-cigarettes with placebo cartridges, and followed for 3 weeks.

Detailed description

This pilot study will be a two-arm, randomized controlled trial. The investigator will randomize 40 participants into each intervention arm. Participants will be randomized to one of the two arms: e-cigarettes with nicotine cartridges or e-cigarettes with placebo cartridges (0mg). Participants and research assistants will be blind to the allocation of nicotine or placebo e-cigarettes as there are no difference in appearance or odor of the mist emitted from the e-cigarettes with and without nicotine containing cartridges. Participants will be asked to track their nicotine use via text message. All participants will receive a 20-30 minute behavioral counseling consultation with a trained tobacco counselor. Counselors will review each participant's smoking pattern and offer tailored behavioral and environmental change strategies including specific smoking reduction strategy options. Participants will be given a supply of e-cigarettes and followed for 3 weeks

Conditions

Interventions

TypeNameDescription
DEVICEe-cigarettesParticipants and research assistants will be blind to the allocation of nicotine or placebo e-cigarettes as there are no difference in appearance or odor of the mist emitted from the e-cigarettes with and without nicotine containing cartridges.

Timeline

Start date
2015-05-01
Primary completion
2018-03-26
Completion
2018-03-26
First posted
2015-12-11
Last updated
2020-02-24
Results posted
2020-02-24

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT02628964. Inclusion in this directory is not an endorsement.